Bone Biologics Corp (BBLGW) Debt Ratio (2013 - 2019)
Bone Biologics (BBLGW) posted quarterly Debt Ratio of 367.21 for Q4 2019, up 9489.51% quarter-over-quarter from 3.83 in Q3 2018.
Bone Biologics Corp (BBLGW) Debt Ratio (2013 - 2019) Analysis & Trends
Bone Biologics (BBLGW) has reported Debt Ratio for 7 consecutive years, with 367.21 the latest figure, recorded in Q4 2019.
- In Q4 2019, Debt Ratio changed N/A year-over-year to 367.21; the TTM figure through Dec 2019 stood at 367.21 (changed N/A YoY), while the FY2019 annual figure was 367.21, changed N/A from the prior year.
- Debt Ratio grew to 367.21 in Q4 2019 per BBLGW's latest filing, from 3.83 in the prior quarter.
- Across five years, Debt Ratio topped out at 367.21 in Q4 2019 and bottomed at 1.17 in Q1 2015.
- Historically, Debt Ratio has averaged 32.72 across 5 years, with a median of 10.71 in 2017.
- Annual changes were most pronounced in 2016 — Debt Ratio soared 414.74% — and 2018, when it sank 68.22%.
- Bone Biologics' Debt Ratio stood at 7.81 in 2015, then jumped by 60.0% to 12.5 in 2016, then retreated by 17.24% to 10.34 in 2017, then slumped by 62.98% to 3.83 in 2018, then jumped by 9489.51% to 367.21 in 2019.
- Business Quant data shows BBLGW's Debt Ratio at 367.21 in Q4 2019, 3.83 in Q3 2018, and 22.67 in Q2 2018.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 367.21 |
| Sep 30, 2018 | 3.83 |
| Jun 30, 2018 | 22.67 |
| Mar 31, 2018 | 17.85 |
| Dec 31, 2017 | 10.34 |
| Sep 30, 2017 | 12.05 |
| Jun 30, 2017 | 21.98 |
| Mar 31, 2017 | 11.09 |
| Dec 31, 2016 | 12.50 |
| Sep 30, 2016 | 19.40 |
| Jun 30, 2016 | 6.28 |
| Mar 31, 2016 | 3.32 |
| Dec 31, 2015 | 7.81 |
| Sep 30, 2015 | 3.77 |
| Jun 30, 2015 | 2.33 |
| Mar 31, 2015 | 1.17 |
| Dec 31, 2014 | 2.26 |
| Sep 30, 2014 | 1.11 |
| Dec 31, 2013 | 0.47 |